Compare Cipla with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA DR. REDDYS LAB CIPLA/
DR. REDDYS LAB
 
P/E (TTM) x 29.9 41.3 72.3% View Chart
P/BV x 4.6 4.5 101.7% View Chart
Dividend Yield % 0.4 0.5 85.0%  

Financials

 CIPLA   DR. REDDYS LAB
EQUITY SHARE DATA
    CIPLA
Mar-20
DR. REDDYS LAB
Mar-21
CIPLA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs5865,515 10.6%   
Low Rs3573,028 11.8%   
Sales per share (Unadj.) Rs212.51,145.4 18.6%  
Earnings per share (Unadj.) Rs19.2114.5 16.8%  
Cash flow per share (Unadj.) Rs32.8188.4 17.4%  
Dividends per share (Unadj.) Rs4.0025.00 16.0%  
Dividend yield (eoy) %0.80.6 145.0%  
Book value per share (Unadj.) Rs194.91,053.2 18.5%  
Shares outstanding (eoy) m806.24166.30 484.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.23.7 59.5%   
Avg P/E ratio x24.637.3 65.8%  
P/CF ratio (eoy) x14.422.7 63.3%  
Price / Book Value ratio x2.44.1 59.6%  
Dividend payout %20.821.8 95.5%   
Avg Mkt Cap Rs m379,858710,289 53.5%   
No. of employees `000NANA-   
Total wages/salary Rs m30,27036,299 83.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m171,320190,475 89.9%  
Other income Rs m3,6942,914 126.8%   
Total revenues Rs m175,014193,389 90.5%   
Gross profit Rs m31,06138,699 80.3%  
Depreciation Rs m11,00012,288 89.5%   
Interest Rs m1,974970 203.5%   
Profit before tax Rs m21,78228,355 76.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,3129,319 67.7%   
Profit after tax Rs m15,47019,036 81.3%  
Gross profit margin %18.120.3 89.2%  
Effective tax rate %29.032.9 88.2%   
Net profit margin %9.010.0 90.4%  
BALANCE SHEET DATA
Current assets Rs m117,062145,503 80.5%   
Current liabilities Rs m43,93181,038 54.2%   
Net working cap to sales %42.733.8 126.1%  
Current ratio x2.71.8 148.4%  
Inventory Days Days5061 81.6%  
Debtors Days Days8395 87.2%  
Net fixed assets Rs m117,166109,979 106.5%   
Share capital Rs m1,613832 193.8%   
"Free" reserves Rs m155,487174,319 89.2%   
Net worth Rs m157,100175,151 89.7%   
Long term debt Rs m23,6936,299 376.1%   
Total assets Rs m234,228255,482 91.7%  
Interest coverage x12.030.2 39.8%   
Debt to equity ratio x0.20 419.4%  
Sales to assets ratio x0.70.7 98.1%   
Return on assets %7.47.8 95.1%  
Return on equity %9.810.9 90.6%  
Return on capital %13.116.2 81.3%  
Exports to sales %32.251.3 62.8%   
Imports to sales %3.418.1 19.1%   
Exports (fob) Rs m55,17597,699 56.5%   
Imports (cif) Rs m5,90334,420 17.1%   
Fx inflow Rs m56,03697,699 57.4%   
Fx outflow Rs m5,90334,420 17.1%   
Net fx Rs m50,13363,279 79.2%   
CASH FLOW
From Operations Rs m30,68535,703 85.9%  
From Investments Rs m1,040-22,660 -4.6%  
From Financial Activity Rs m-29,488-298 9,895.4%  
Net Cashflow Rs m2,34012,858 18.2%  

Share Holding

Indian Promoters % 15.0 26.7 56.1%  
Foreign collaborators % 21.7 0.0 -  
Indian inst/Mut Fund % 41.1 44.8 91.7%  
FIIs % 24.8 29.0 85.5%  
ADR/GDR % 0.0 12.1 -  
Free float % 63.3 61.2 103.4%  
Shareholders   408,401 223,309 182.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   FREDUN PHARMA  CORAL LAB.  ASTRAZENECA PHARMA  IND. SWIFT  CONCORD DRUGS  



Today's Market

Sensex Recovers 640 Points from Day's Low; Dr Reddy's Laboratories & Kotak Mahindra Bank Among Top Nifty Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Announces Quarterly Results (1QFY21); Net Profit Up 21.4% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, CIPLA has posted a net profit of Rs 6 bn (up 21.4% YoY). Sales on the other hand came in at Rs 43 bn (up 7.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (4QFY20); Net Profit Down 35.1% (Quarterly Result Update)

May 19, 2020 | Updated on May 19, 2020

For the quarter ended March 2020, CIPLA has posted a net profit of Rs 2 bn (down 35.1% YoY). Sales on the other hand came in at Rs 44 bn (down 0.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (3QFY20); Net Profit Up 9.4% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, CIPLA has posted a net profit of Rs 4 bn (up 9.4% YoY). Sales on the other hand came in at Rs 44 bn (up 9.1% YoY). Read on for a complete analysis of CIPLA's quarterly results.

More Views on News

Most Popular

RBI Opens a New Market for Investors(Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

These Are the Best Stocks to Own(Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

India's Vulture Moment Against China(Fast Profits Daily)

Jul 15, 2021

India has a great opportunity to grab market share from China. Profit from it.

Top 5 Stocks Mutual Funds Bought and Sold in June 2021(Views On News)

Jul 15, 2021

A look at what India's top equity mutual funds bought and sold in June 2021.

Zomato: Worth a Bite?(Profit Hunter)

Jul 15, 2021

Zomato has been a consumer's delight. Can it be an investor's delight too?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Jul 28, 2021 (Close)

TRACK CIPLA

COMPARE CIPLA WITH

MARKET STATS